0.011990
0.000000
0.000000
0.000000
0.008292
0.000000
0.000000
0.000000
0.026525
0.00000
0.00000
0.00000
SER 37 - PRO 38 OMEGA = 96.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
CIS PROLINE - PRO 91
Acharya, K.R.
Allen, S.
Shapiro, R.
Riordan, J.F.
Vallee, B.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
83.400
120.600
37.700
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
91
2915
2919
10.1073/pnas.91.8.2915
8159679
Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease.
1994
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
228
1269
Crystallization and Preliminary X-Ray Analysis of Human Angiogenin
1992
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
x-ray
1
1.0
14169.036
ANGIOGENIN
1
man
polymer
no
no
QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT
CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP
QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT
CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
3.34
63.21
repository
Initial release
Version format compliance
Version format compliance
1
0
1995-04-20
1
1
2008-03-03
1
2
2011-07-13
Y
1994-01-18
REL
GLN
1
n
1
GLN
1
A
ASP
2
n
2
ASP
2
A
ASN
3
n
3
ASN
3
A
SER
4
n
4
SER
4
A
ARG
5
n
5
ARG
5
A
TYR
6
n
6
TYR
6
A
THR
7
n
7
THR
7
A
HIS
8
n
8
HIS
8
A
PHE
9
n
9
PHE
9
A
LEU
10
n
10
LEU
10
A
THR
11
n
11
THR
11
A
GLN
12
n
12
GLN
12
A
HIS
13
n
13
HIS
13
A
TYR
14
n
14
TYR
14
A
ASP
15
n
15
ASP
15
A
ALA
16
n
16
ALA
16
A
LYS
17
n
17
LYS
17
A
PRO
18
n
18
PRO
18
A
GLN
19
n
19
GLN
19
A
GLY
20
n
20
GLY
20
A
ARG
21
n
21
ARG
21
A
ASP
22
n
22
ASP
22
A
ASP
23
n
23
ASP
23
A
ARG
24
n
24
ARG
24
A
TYR
25
n
25
TYR
25
A
CYS
26
n
26
CYS
26
A
GLU
27
n
27
GLU
27
A
SER
28
n
28
SER
28
A
ILE
29
n
29
ILE
29
A
MET
30
n
30
MET
30
A
ARG
31
n
31
ARG
31
A
ARG
32
n
32
ARG
32
A
ARG
33
n
33
ARG
33
A
GLY
34
n
34
GLY
34
A
LEU
35
n
35
LEU
35
A
THR
36
n
36
THR
36
A
SER
37
n
37
SER
37
A
PRO
38
n
38
PRO
38
A
CYS
39
n
39
CYS
39
A
LYS
40
n
40
LYS
40
A
ASP
41
n
41
ASP
41
A
ILE
42
n
42
ILE
42
A
ASN
43
n
43
ASN
43
A
THR
44
n
44
THR
44
A
PHE
45
n
45
PHE
45
A
ILE
46
n
46
ILE
46
A
HIS
47
n
47
HIS
47
A
GLY
48
n
48
GLY
48
A
ASN
49
n
49
ASN
49
A
LYS
50
n
50
LYS
50
A
ARG
51
n
51
ARG
51
A
SER
52
n
52
SER
52
A
ILE
53
n
53
ILE
53
A
LYS
54
n
54
LYS
54
A
ALA
55
n
55
ALA
55
A
ILE
56
n
56
ILE
56
A
CYS
57
n
57
CYS
57
A
GLU
58
n
58
GLU
58
A
ASN
59
n
59
ASN
59
A
LYS
60
n
60
LYS
60
A
ASN
61
n
61
ASN
61
A
GLY
62
n
62
GLY
62
A
ASN
63
n
63
ASN
63
A
PRO
64
n
64
PRO
64
A
HIS
65
n
65
HIS
65
A
ARG
66
n
66
ARG
66
A
GLU
67
n
67
GLU
67
A
ASN
68
n
68
ASN
68
A
LEU
69
n
69
LEU
69
A
ARG
70
n
70
ARG
70
A
ILE
71
n
71
ILE
71
A
SER
72
n
72
SER
72
A
LYS
73
n
73
LYS
73
A
SER
74
n
74
SER
74
A
SER
75
n
75
SER
75
A
PHE
76
n
76
PHE
76
A
GLN
77
n
77
GLN
77
A
VAL
78
n
78
VAL
78
A
THR
79
n
79
THR
79
A
THR
80
n
80
THR
80
A
CYS
81
n
81
CYS
81
A
LYS
82
n
82
LYS
82
A
LEU
83
n
83
LEU
83
A
HIS
84
n
84
HIS
84
A
GLY
85
n
85
GLY
85
A
GLY
86
n
86
GLY
86
A
SER
87
n
87
SER
87
A
PRO
88
n
88
PRO
88
A
TRP
89
n
89
TRP
89
A
PRO
90
n
90
PRO
90
A
PRO
91
n
91
PRO
91
A
CYS
92
n
92
CYS
92
A
GLN
93
n
93
GLN
93
A
TYR
94
n
94
TYR
94
A
ARG
95
n
95
ARG
95
A
ALA
96
n
96
ALA
96
A
THR
97
n
97
THR
97
A
ALA
98
n
98
ALA
98
A
GLY
99
n
99
GLY
99
A
PHE
100
n
100
PHE
100
A
ARG
101
n
101
ARG
101
A
ASN
102
n
102
ASN
102
A
VAL
103
n
103
VAL
103
A
VAL
104
n
104
VAL
104
A
VAL
105
n
105
VAL
105
A
ALA
106
n
106
ALA
106
A
CYS
107
n
107
CYS
107
A
GLU
108
n
108
GLU
108
A
ASN
109
n
109
ASN
109
A
GLY
110
n
110
GLY
110
A
LEU
111
n
111
LEU
111
A
PRO
112
n
112
PRO
112
A
VAL
113
n
113
VAL
113
A
HIS
114
n
114
HIS
114
A
LEU
115
n
115
LEU
115
A
ASP
116
n
116
ASP
116
A
GLN
117
n
117
GLN
117
A
SER
118
n
118
SER
118
A
ILE
119
n
119
ILE
119
A
PHE
120
n
120
PHE
120
A
ARG
121
n
121
ARG
121
A
ARG
122
n
122
ARG
122
A
PRO
123
n
123
PRO
123
A
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
3_555
-x,y,-z+1/2
crystal symmetry operation
0.0000000000
0.0000000000
18.8500000000
A
O
ASN
43
A
O
ASN
43
A
N
CYS
81
A
N
CYS
81
A
N
THR
80
A
N
THR
80
A
O
THR
97
A
O
THR
97
A
N
ARG
70
A
N
ARG
70
A
O
VAL
105
A
O
VAL
105
A
N
ALA
106
A
N
ALA
106
A
O
HIS
114
A
O
HIS
114
1
A
A
SER
PRO
37
38
96.94
1
17.44
2.70
111.00
128.44
A
A
A
N
CA
C
GLN
GLN
GLN
1
1
1
N
1
4.29
0.50
120.30
124.59
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
5
5
5
N
1
-3.55
0.50
120.30
116.75
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
31
31
31
N
1
3.98
0.50
120.30
124.28
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
32
32
32
N
1
3.79
0.50
120.30
124.09
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
33
33
33
N
1
6.77
1.10
114.20
120.97
A
A
A
CA
CB
SG
CYS
CYS
CYS
39
39
39
N
1
4.48
0.50
120.30
124.78
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
66
66
66
N
1
-3.25
0.50
120.30
117.05
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
66
66
66
N
1
5.98
0.80
106.30
112.28
A
A
A
CD1
CG
CD2
TRP
TRP
TRP
89
89
89
N
1
-5.73
0.80
107.30
101.57
A
A
A
CE2
CD2
CG
TRP
TRP
TRP
89
89
89
N
1
3.02
0.50
120.30
123.32
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
101
101
101
N
1
-4.63
0.50
120.30
115.67
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
101
101
101
N
1
17.64
2.30
115.30
132.94
A
A
A
CA
CB
CG
LEU
LEU
LEU
115
115
115
N
1
A
A
NE2
CD2
HIS
HIS
13
13
-0.074
0.011
1.373
1.299
N
1
A
ASN
3
66.06
-32.45
1
A
SER
4
-38.29
-20.23
1
A
GLN
19
-96.17
-82.75
1
A
ARG
66
49.89
-149.44
0.22
0.22
2.4
8.0
6609
1
0.0
2.4
8.0
0
993
0
0
993
0.015
3.51
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
ANGIOGENIN
CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE
1
N
N
A
ASN
3
A
ASN
3
HELX_P
A
TYR
14
A
TYR
14
1
H1
12
A
ARG
21
A
ARG
21
HELX_P
A
ARG
33
A
ARG
33
1
H2
13
A
ASN
49
A
ASN
49
HELX_P
A
GLU
58
A
GLU
58
1
H3
10
A
GLN
117
A
GLN
117
HELX_P
A
PHE
120
A
PHE
120
5
H4
4
disulf
2.021
A
CYS
26
A
SG
CYS
26
1_555
A
CYS
81
A
SG
CYS
81
1_555
disulf
2.005
A
CYS
39
A
SG
CYS
39
1_555
A
CYS
92
A
SG
CYS
92
1_555
disulf
2.002
A
CYS
57
A
SG
CYS
57
1_555
A
CYS
107
A
SG
CYS
107
1_555
HYDROLASE (VASCULARIZATION)
HYDROLASE (VASCULARIZATION)
A
PRO
90
A
PRO
90
1
A
PRO
91
A
PRO
91
7.62
ANGI_HUMAN
UNP
1
1
P03950
MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAI
CENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP
25
147
1ANG
1
123
P03950
A
1
1
123
3
3
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ASP
41
A
ASP
41
A
HIS
47
A
HIS
47
A
PHE
76
A
PHE
76
A
HIS
84
A
HIS
84
A
GLN
93
A
GLN
93
A
ARG
101
A
ARG
101
A
LEU
69
A
LEU
69
A
LYS
73
A
LYS
73
A
VAL
103
A
VAL
103
A
GLU
108
A
GLU
108
A
LEU
111
A
LEU
111
A
ASP
116
A
ASP
116
Unknown
8
Unknown
10
A
GLN
12
A
GLN
12
8
1_555
A
HIS
13
A
HIS
13
8
1_555
A
LYS
40
A
LYS
40
8
1_555
A
THR
44
A
THR
44
8
1_555
A
GLU
108
A
GLU
108
8
1_555
A
HIS
114
A
HIS
114
8
1_555
A
GLN
117
A
GLN
117
8
1_555
A
SER
118
A
SER
118
8
1_555
A
LYS
60
A
LYS
60
10
1_555
A
ASN
61
A
ASN
61
10
1_555
A
GLY
62
A
GLY
62
10
1_555
A
ASN
63
A
ASN
63
10
1_555
A
PRO
64
A
PRO
64
10
1_555
A
HIS
65
A
HIS
65
10
1_555
A
ARG
66
A
ARG
66
10
1_555
A
GLU
67
A
GLU
67
10
1_555
A
ASN
68
A
ASN
68
10
1_555
A
ASN
109
A
ASN
109
10
1_555
20
C 2 2 21